These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27347941)

  • 1. Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes.
    Costa V; Federico A; Pollastro C; Ziviello C; Cataldi S; Formisano P; Ciccodicola A
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the Gly972Arg, SNP43 and Prol2Ala polymorphisms of the genes IRS1, CAPN10 and PPARG2 on secondary failure to sulphonylurea and metformin in patients with type 2 diabetes in Yucatán, México].
    García-Escalante MG; Suárez-Solís VM; López-Avila MT; Pinto-Escalante Ddel C; Laviada-Molina H
    Invest Clin; 2009 Mar; 50(1):65-76. PubMed ID: 19418728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAPN10 mRNA splicing and decay is not affected by a SNP associated with susceptibility to type 2 diabetes.
    López-Orduña E; García-Mena J; García-Macedo R; Stumvoll M; Cruz M
    Biochem Biophys Res Commun; 2007 Jul; 358(3):831-6. PubMed ID: 17511963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients.
    Zaharenko L; Kalnina I; Geldnere K; Konrade I; Grinberga S; Židzik J; Javorský M; Lejnieks A; Nikitina-Zake L; Fridmanis D; Peculis R; Radovica-Spalvina I; Hartmane D; Pugovics O; Tkáč I; Klimčáková L; Pīrāgs V; Klovins J
    Eur J Endocrinol; 2016 Dec; 175(6):531-540. PubMed ID: 27609360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of IRS1, CAPN10, and PPARG gene polymorphisms with type 2 diabetes mellitus in the high-risk population of Hyderabad, India.
    Kommoju UJ; Maruda J; Kadarkarai Samy S; Irgam K; Kotla JP; Reddy BM
    J Diabetes; 2014 Nov; 6(6):564-73. PubMed ID: 24612564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of APOE polymorphisms with diabetes and cardiometabolic risk factors and the role of APOE genotypes in response to anti-diabetic therapy: results from the AIDHS/SDS on a South Asian population.
    Sapkota B; Subramanian A; Priamvada G; Finely H; Blackett PR; Aston CE; Sanghera DK
    J Diabetes Complications; 2015; 29(8):1191-7. PubMed ID: 26318958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPARγ and Diabetes: Beyond the Genome and Towards Personalized Medicine.
    Cataldi S; Costa V; Ciccodicola A; Aprile M
    Curr Diab Rep; 2021 Apr; 21(6):18. PubMed ID: 33866450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
    Pollastro C; Ziviello C; Costa V; Ciccodicola A
    PPAR Res; 2015; 2015():415149. PubMed ID: 26161088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A replication study of the IRS1, CAPN10, TCF7L2, and PPARG gene polymorphisms associated with type 2 diabetes in two different populations of Mexico.
    Martínez-Gómez LE; Cruz M; Martínez-Nava GA; Madrid-Marina V; Parra E; García-Mena J; Espinoza-Rojo M; Estrada-Velasco BI; Piza-Roman LF; Aguilera P; Burguete-García AI
    Ann Hum Genet; 2011 Sep; 75(5):612-20. PubMed ID: 21834909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes.
    Tkáč I; Javorský M; Klimčáková L; Židzik J; Gaľa I; Babjaková E; Schroner Z; Štolfová M; Hermanová H; Habalová V
    Eur J Clin Pharmacol; 2015 Jan; 71(1):59-63. PubMed ID: 25327507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].
    Winkler G
    Orv Hetil; 2016 Jun; 157(23):882-91. PubMed ID: 27233831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-associated coding synonymous SNPs in type 2 diabetes and neurodegenerative diseases: genetic silence and the underrated association with splicing regulation and epigenetics.
    Karambataki M; Malousi A; Kouidou S
    Mutat Res; 2014 Dec; 770():85-93. PubMed ID: 25771874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in FTO and near TMEM18 associate with type 2 diabetes and predispose to younger age at diagnosis of diabetes.
    Kalnina I; Zaharenko L; Vaivade I; Rovite V; Nikitina-Zake L; Peculis R; Fridmanis D; Geldnere K; Jacobsson JA; Almen MS; Pirags V; Schiöth HB; Klovins J
    Gene; 2013 Sep; 527(2):462-8. PubMed ID: 23860325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population genetics of CAPN10 and GPR35: implications for the evolution of type 2 diabetes variants.
    Vander Molen J; Frisse LM; Fullerton SM; Qian Y; Del Bosque-Plata L; Hudson RR; Di Rienzo A
    Am J Hum Genet; 2005 Apr; 76(4):548-60. PubMed ID: 15696418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carriage of risk variants of CDKAL1 impairs beta-cell function in both diabetic and non-diabetic patients and reduces response to non-sulfonylurea and sulfonylurea agonists of the pancreatic KATP channel.
    Chistiakov DA; Potapov VA; Smetanina SA; Bel'chikova LN; Suplotova LA; Nosikov VV
    Acta Diabetol; 2011 Sep; 48(3):227-35. PubMed ID: 21611789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin.
    Li S; Xu B; Fan S; Kang B; Deng L; Chen D; Yang B; Tang F; He Z; Xue Y; Zhou JC
    Expert Rev Clin Pharmacol; 2022 Sep; 15(9):1107-1117. PubMed ID: 36065506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk.
    Segrè AV; Wei N; ; ; Altshuler D; Florez JC
    Diabetes; 2015 Apr; 64(4):1470-83. PubMed ID: 25368101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Role for an Old Drug: Metformin Targets MicroRNAs in Treating Diabetes and Cancer.
    Zhou JY; Xu B; Li L
    Drug Dev Res; 2015 Sep; 76(6):263-9. PubMed ID: 26936407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic testing of constitutive sensitivity to metformin in cancer patients with and without diabetes].
    Bershteĭn LM; Vasil'ev DA; Ievleva AG; Imianitov EN
    Vopr Onkol; 2013; 59(6):714-20. PubMed ID: 24624779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haplotype structure and phylogenetic shadowing of a hypervariable region in the CAPN10 gene.
    Clark VJ; Cox NJ; Hammond M; Hanis CL; Di Rienzo A
    Hum Genet; 2005 Jul; 117(2-3):258-66. PubMed ID: 15906097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.